Table 2 illustrates salient features based on regional involvement, including duration, mode of onset, and distribution of pain; proportion of patients with previous surgery; and the number of joints involved.
21 23 The interviewer asked directly about pain and its severity, without asking about the duration of pain, proportion of menstruations affected or activities that could not be completed owing to the pain.
The EMA also granted additional claim language in the SmPC for abiraterone, including "time to pain degradation," "proportion of patients with pain palliation," and "proportion of patients with pain progression" based on the BPI-SF worst pain item.
Secondary outcome measures include total opioid dose, opioid side effects, patient satisfaction with pain management, proportion of study period with VAS >44 mm, proportion of study period spent sleeping, length of hospital stay and incremental cost effectiveness ratio (ICER).
23 Secondary outcome measures included total opioid dose, out of range vital signs, patients satisfaction with pain management, proportion of study period in moderate/severe pain (that is with visual analogue scale >4.4 cm), proportion of study period spent sleeping, and length of hospital stay.
22 Secondary outcome measures included total opioid dose, opioid side effects, patients satisfaction with pain management, proportion of study period in moderate/severe pain (that is, with visual analogue scale >44 mm), proportion of study period spent sleeping, and length of hospital stay.
In other words, also for mid back pain, the proportion of spinal pathologies may in fact be very low.
However, with higher intensity of pain, the proportion decreases to 3.5 in pain level 4, to 2.4 in pain level 5 and <1 in pain level 6.
On the other hand, in examinations on other indications than pain the proportion of positive findings was high in the CWP group (62.5% vs 14.8%; p = 0.001).
On the other hand, if the indication for the examination was other than pain, the proportion of positive findings in subjects with longstanding/reoccurring CWP was as high as 62,5%, compared to 14.8% amongst all others (p = 0.001; Table 5).
Similar to the decrease in hip flexion range and pain, the proportion of patients with a walking capacity <30 min. constantly increases up to 64% in the year of the revision.
